Sanofi SA logo

Sanofi SA (SNW)

Market Closed
10 Jun, 09:01
75. 99
-0.95
-1.2347%
- Market Cap
- P/E Ratio
15.68% Div Yield
93 Volume
0 Eps
76.94
Previous Close
Add Transaction
Day Range
75.99 76.57
Year Range
72.46 90.19
Want to track SNW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SNW closed Wednesday lower at €75.99, a decrease of -1.2347% from Tuesday's close, completing a monthly increase of 0.9431% or €0.71. Over the past 12 months, SNW stock lost -8.1026%.
SNW is not paying dividends to its shareholders.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.9%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on LSE (EUR).

SNW Chart

Sanofi SA (SNW) FAQ

What is the stock price today?

The current price is €75.99.

On which exchange is it traded?

Sanofi SA is listed on XMUN.

What is its stock symbol?

The ticker symbol is SNW.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 15.68%.

What is its market cap?

As of today, no market cap data is available.

Has Sanofi SA ever had a stock split?

No, there has never been a stock split.

Sanofi SA Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Adam Buchajski CEO
XMUN Exchange
FR0000120578 ISIN
Poland Country
88 Employees
5 May 2026 Last Dividend
- Last Split
- IPO Date
Sanofi SA is a French multinational pharmaceutical and healthcare company headquartered in Paris, renowned for its research, development, manufacturing, and marketing of innovative medicines and vaccines. Established in 1973, it has evolved through key mergers, including with Synthélabo in 1999 and Aventis in 2004, forming a global leader with over 90,000 employees across 90 countries. Sanofi focuses on seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines, positioning it as the world's largest vaccine producer via its Sanofi Pasteur subsidiary. Its portfolio spans prescription drugs like Dupixent for eczema and autoimmune conditions, Lovenox for thrombosis, Taxotere for cancer, and treatments for rare diseases such as Gaucher's and hemophilia. Sanofi also offers over-the-counter products including Allegra and IcyHot. As an R&D-driven, AI-powered biopharma entity, it invests heavily in immunology, neurology, diabetes innovation, and mRNA technologies, maintaining a robust pipeline of 80 compounds in clinical development across five therapeutic areas to address unmet medical needs and advance public health worldwide.

Contact Information

Address: ul. Cisowa 11
Phone: 48 81 444 6480